General Statistics on Road Traffic Accidents
Driving a car is a central part of life in developed societies. For example, more than 85% of Americans own a car and almost 270 million vehicles are registered in the US alone (of which more than 190 million are "light duty, short wheel base" vehicles). 3 However, motor vehicle accidents are a leading cause of death worldwide.
Road injuries -including accidents involving all forms of road transportation systems, and pedestrians -killed more than 1.4 million people in 2016. 4 In UK, 1,793 people were killed in road accidents in 2017, 44% of which were drivers. 5 The risk of death related to driving is highly variable between countries.
Road traffic death rates in low-and middle-income countries are more than double those in high-income countries. 6 However, wide disparities exist even among developed countries. For example, per capita road fatalities in the US are almost double those in Denmark, and in 2016 there was almost a fourfold difference in road accident fatalities between the 'safest' and the 'least safe' European countries:
Norway (26 fatalities per million population) and Romania (97 fatalities per million population). 7, 8 While some of the difference may relate to mileage driven, cultural approaches to risk are also an important factor.
Accident and fatality rates also vary according to age. The rate of death in car accidents is highest in individuals aged 20-29 years and those older than 80 years -16.0 per million population in the UK -and lowest in the middle-aged population -6.8 per million population in the UK -in those aged 40-49 years. 9 In young adults aged 20-29, road traffic accidents are the leading cause of death worldwide. 6 Elderly people are at risk of road traffic accidents for a variety of reasons, such as a slower reaction time, depth perception change, vision and hearing problems, decreased ability to focus and medical problems.
Compared with younger individuals -for who speed is a major cause of road accidents while driving -physiological and perceptual decline is the major cause of road accidents while driving in older individuals. 10 
Acceptable Risk of Road Traffic Accidents
Driving carries risk but is a major part of life in many societies, so it follows that these societies accept an intrinsic risk of harm (RH) to self and others because of driving. Nationally defined regulations have implicitly balanced risk and benefit for decades. An attempt to formalise this balancing act emerged from a Canadian Cardiovascular Society conference in 1992 (updated in 2003). 11 In this document, the annual RH as a result of driving was defined as: RH = TD × V × SCI × Ac where:
• TD is the time spent driving;
• V is the type of vehicle;
• SCI is the risk of sudden incapacitation; and
• Ac is the probability that an episode of sudden incapacitation will result in a fatal or injury-producing accident.
-TD is 0.25 (25%) for professional drivers because the average time spent driving is 6 hours per day; and 0.04 (4%) for social drivers because they spend, on average, 1 hour driving per day.
-V is 1 for trucks and 0.28 for family cars because, on average, accidents involving trucks cause 7.2% of fatalities, despite causing only 2.0% of road accidents (2.0 ÷ 7.2% = 0.28).
-SCI is 0.01 (1%), which was the estimated annual risk of SCD of a truck driver who had not had an acute MI within the previous 3 months, is in functional class I (asymptomatic), has a negative exercise tolerance test, is able to perform at least seven metabolic equivalents of task during the treadmill test, and has no documented ventricular arrhythmias. This driver was historically allowed to drive by Canadian laws, so this was set as the acceptable risk threshold in the RH formula. The 1% mortality per year also holds true for men in the Western population aged >65 years and this limit has been used for maximal annual risk allowance for commercial pilots in aviation risk assessment (the 1% rule).
12 See Table 2 for full details of syncope guidance depending on country or guideline document. We endorse the recommendations valid in the UK on driving restrictions for patients with syncope, supraventricular tachycardia, following ablation procedures and with pacemaker devices. Our personal opinion regarding private drivers with ICDs will be discussed briefly below.
ICDs
In 2011, around 400,000 ICDs were implanted each year worldwide, two-thirds of which were new implants. 19 ICDs are implanted for primary or secondary prevention of SCD. Primary prevention refers to patients who have never had but are at risk of having a VT/VF event.
Secondary prevention refers to patients who have had a VT/VF event.
There are a variety of conditions that may predispose a patient to SCD and each carries a particular risk. In the adult population, the majority of SCD events -approximately 80% -appear in patients with coronary artery disease. 20, 21 ICDs are effective in treating sudden ventricular tachyarrhythmic events that can cause SCD. However, ICDs do not prevent such events.
With VF, loss of consciousness is usual as the ICD typically takes 10-15 seconds to deliver therapy (longer for subcutaneous ICDs). As such, establishing the risk of syncopal events caused by VT/VF in patients with ICDs is important to assess the RH.
The average annual risk of shock while driving in patients with ICDs is approximately 1.5%. 22 Studies have documented that the risk of syncope associated with appropriate ICD shocks in patients who have had an ICD implanted for secondary prevention ranges from 2.0% to 16 .0% (average 11.2%). 10 For primary prevention, the risk of syncope inappropriate ICD shock-on-T-wave as a result of T-wave oversensing. 24 The calculated RH for inappropriate ICD therapies associated with syncope was <0.0008% for both primary and secondary prevention ICD indications, leading the authors to conclude that inappropriate ICD shocks should not result in a driving ban. 24 Current data suggest that there is an increased risk of ICD shocks early after ICD implantation -for both primary and secondary preventionand following appropriate or inappropriate ICD shocks, but the risk rapidly diminishes over the next 6 months. Thijssen et al. analysed data from 2,786 patients with primary and secondary prevention ICDs. Using the societal threshold for the RH of 0.005%, the 95% CI of the annual RH following ICD implantation was always below the threshold for both primary and secondary prevention, suggesting that no specific period of restriction after implantation is appropriate for private drivers.
Following appropriate ICD shocks -and using a historical estimated risk of syncope associated with appropriate ICD shocks of 31% -the 95% CI of the annual RH fell below the threshold at 6 months for primary prevention ICDs, and at 3 months for secondary prevention ICDs. For commercial drivers, the RH was always above the threshold, supporting a permanent driving ban. 25 However, newer data on contemporary ICD patient populations with modern ICD programingand a more contemporary estimated risk of syncope associated with ICD shocks of 14% -suggest that the RH falls below 0.005% only 1 month after appropriate shocks. 26 Thijssen et al. also estimated the RH after inappropriate shocks, but they assumed that the risk of syncope associated with ICD shocks is identical (31%) regardless of whether the shock was appropriate or not, which likely resulted in significantly overestimated RH (the 95% CI of the annual RH fell below 0.005% at 1 month and 3 months for appropriate and inappropriate shocks, respectively). 25 As mentioned, newer data suggest that driving restrictions may not be necessary after inappropriate shock therapy. 24 It is important to realise though that there are several important limitations regarding the RH assessment in patients with ICDs. First, as discussed, the RH threshold of 0.005% has been historically accepted for Canadian populations based on Canadian road traffic accident data from more than 30 years ago. Second, the risk of SCD and ICD shocks has been largely based on populations from the 1990s and early 2000s but there has been an almost 70% reduction of mortality in patients with coronary artery disease and heart failure in the last 20 years and a 44% reduction in SCD rates between 1995 and 2014 in patients with heart failure and reduced ejection fraction. 27, 28 These dramatic changes were a result of more effective drug treatment, e.g.
angiotensin converting enzyme inhibitors, early revascularisation in patients with acute coronary syndromes, implementation of cardiac resynchronisation therapy, and so on. Indeed, in non-ischaemic dilated cardiomyopathy, the Danish Study to Assess the Efficacy of ICDs in
Patients with Non-ischemic Systolic Heart Failure on Mortality (DANISH) failed to show a benefit of ICDs in reducing mortality, compared with the 11-year older Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT).
However, the overall absolute 5-year mortality rate in the DANISH was approximately 10% lower than in the SCD-HeFT. 29, 30 As such, the risk of sudden incapacity while driving in contemporary patients with ICD may well be lower than the historical data upon which the current recommendations and legislations are based would suggest.
Based on the summary above, we think that the current driving restrictions for patients with ICDs holding a group 1 driving licence are, in some cases, too restrictive. We propose that the following driving restrictions should suffice for these patients, if they drive in countries where the road safety statistics are similar to the countries mentioned in Table 2 : 
Legislation and Disclosure of Patient Information

Driving Regulations and Expert Consensus Documents
In many countries driving regulations have evolved over time as new data on clinical outcomes have become available. For example, in the UK, driving with an ICD was initially completely prohibited. By 1994 driving was allowed 2 years after ICD implant and by 2000 the regulations evolved to allow driving 1 month after a primary prevention ICD and 6 months after a secondary prevention ICD. [31] [32] [33] Regulations are made to provide a balance between the privilege of driving and the potential to harm others from driving. It can be argued that, based on cultural and social mentality, national legislation will find different levels of equilibrium between these two opposing forces. In addition to national regulations, professional bodies have published guidance relating to particular areas of interest, such as licensing in ICD patients. [34] [35] [36] The different national regulations and physician recommendations are summarised in Adherence with physician recommendations regarding driving is low in patients with ICD, with approximately one-third of patients not adhering to these recommendations. 22 Patients frequently perceive the driving restrictions as a loss of independence and change in self-image.
Often patients resume driving because of a misunderstanding about their condition and the risks involved, or because they think it is their decision not others to make. 47 Education about the rationale for driving restrictions is important for ICD patients.
In a situation where a physician becomes aware that a patient is not adhering to the local driving code, an ethical issue arises about what to do. In the US, the recommended ethical action for doctors who are involved in the care of patients with conditions that constitute a ban from driving is to disclose that information to the police, after informing the patient, even if the patient refuses to obey. 36 The reasoning is that ethical responsibilities of beneficence (do good and avoid evil) and non-maleficence (do no harm) take precedence over the principle of confidentiality in this setting. In Canada, disclosure of patients' information by physicians is mandatory in most states, but not in all (for example, reporting is discretionary in Alberta, Nova Scotia and Quebec). 11 In the UK, doctors should inform patients about conditions and treatments that might affect their ability to drive and remind them of their duty to tell the appropriate agency. 33 If a patient refuses or is found not to have told the appropriate agency, doctors should ask for a patient's consent to disclose information to the authorities, unless the information "is required by law or if it is not safe, appropriate or practicable to do so". 48 In Germany, because of confidentiality law, the doctor should only inform the patient regarding the loss of fitness to drive; informing the authorities is not permitted. 37 In Japan, the doctor should advise patients not to drive if they have had syncope or are at risk of syncope. Also, the doctor is recommended to advise about conditions or treatments that might affect the patient's ability to drive to the National Public Safety Commission (Watanabe E, personal communication). 
Conclusion
Clinical Perspective
• There is significant national variation in regulation of fitness to drive in patients at risk of sudden incapacitation, and the approach to its implementation.
• Much of the scientific data that back up current recommendations are historical and may not accurately reflect changes in vehicles and the driving environment, along with possible changes in societal acceptance of risk.
• In future, methods to estimate the individual risk of harm while driving may prove useful.
• The development of new technologies such as driverless vehicles may have an impact on society's willingness to accept excess risk as a result of medical conditions.
